Company profile for Prevencio Med

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Prevencio utilizes Machine Learning (Artificial Intelligence) + Multi-Proteomic Biomarkers + Proprietary Algorithms to deliver cardiovascular diagnostic & prognostic tests that are significantly more accurate than standard-of-care stress tests, individual biomarkers, genetic markers and clinical risk scores. Enrichment of clinical trials for pharmaceuticals and medical devices through more accurate selection and monitoring of ...
Prevencio utilizes Machine Learning (Artificial Intelligence) + Multi-Proteomic Biomarkers + Proprietary Algorithms to deliver cardiovascular diagnostic & prognostic tests that are significantly more accurate than standard-of-care stress tests, individual biomarkers, genetic markers and clinical risk scores. Enrichment of clinical trials for pharmaceuticals and medical devices through more accurate selection and monitoring of patients. Prevencio's patent-pending use of Multi-Proteomic Biomarkers, Clinical Variables and Proprietary Algorithms have delivered a Product Pipeline of six (6) tests with more in development. ​

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
11335 NE 122nd Way, Suite 105 Kirkland, WA 98034
Telephone
Telephone
425-576-1200
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.biospace.com/article/releases/prevencio-and-memorial-sloan-kettering-cancer-center-data-demonstrates-significant-correlation-of-ai-driven-hart-cve-blood-test-scores-with-development-of-adverse-heart-events-following-cancer-radiation-treatment/?s=71

BIOSPACE
27 Oct 2021

https://www.fiercebiotech.com/medtech/bayer-to-back-11-startups-various-digital-health-enterprises

Conor Hale FIERCE BIOTECH
14 Oct 2019

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty